Elucidation of the cytogenotoxic potential of vigabatrin and its in silico computer-assisted DNA interaction

References

• Abdulfatai, U., Uzairu, A., and Uba, S., 2018. Molecular docking and quantitative structure-activity relationship study of anticonvulsant activity of aminobenzothiazole derivatives. Beni-Suef University Journal of Basic and Applied Sciences, 7 (2), 204–214.
   Google Scholar
• Abdulrazzaq, Y.M., and Bastaki, S.M., and Padmanabhan, R., 1997. Teratogenic effects of vigabatrinin TO mouse fetuses. Teratology, 55 (3), 165–176.
   PubMedGoogle Scholar
• Albertini, R.J., et al., 2000. IPCS guidelines for the monitoring of genotoxic effects of carcinogens in humans. Mutation research, 463 (2), 111–172.
   PubMed Web of Science ®Google Scholar
• Al-Obaidi, A., Elmezayen, A.D., and Yelekçi, K., 2020. Homology modeling of human GABA-AT and devise some novel and potent inhibitors via computer-aided drug design techniques. Journal of Biomolecular Structure and Dynamics, 39 (11), 4100–4110.
   PubMed Web of Science ®Google Scholar
• Aouad, M.R., et al., 2021. Novel 1, 2, 3‐triazole derivatives as potential ınhibitors against covid‐19 main protease: synthesis, characterization, molecular docking and DFT studies. ChemistrySelect, 6 (14), 3468–3486.
   PubMed Web of Science ®Google Scholar
• Armstrong, M.J., Bean, C.L., and Galloway, S.M., 1992. A quantitative assessment of cytotoxicity associated with chromosomal aberration detection in chinese hamster ovary cells. Mutation research, 265 (1), 45–60.
   PubMed Web of Science ®Google Scholar
• Battino, D., and Tomson, T., 2007. Management of epilepsy during pregnancy. Drugs, 67 (18), 2727–2746.
   PubMed Web of Science ®Google Scholar
• Carrano, A.V., and Natarajan, A.T., 1988. Consideration for population monitoring using cytogenetic techniques. Mutation research, 204 (3), 379–406.
   PubMed Web of Science ®Google Scholar
• Coelho, V.R., et al., 2016. Genotoxic and mutagenic effects of vigabatrin, a γ-aminobutyric acid transaminase ınhibitor, in wistar rats submitted to rotarod task. Human & Experimental Toxicology, 35 (9), 958–965.
   PubMed Web of Science ®Google Scholar
• Collins, A.R., 2015. The comet assay: a heavenly method!. Mutagenesis, 30 (1), 1–4.
   PubMed Web of Science ®Google Scholar
• De Santis, M., et al., 2008. Prenatal drug exposure and teratological risk: one-year experience of an Italian Teratology Information Service. Medical science Monitor : international Medical Journal of Experimental and Clinical Research, 14 (2), PH1–PH8.
   PubMed Web of Science ®Google Scholar
• Dermitzoglou, G., et al., 2013. Pregabalin’s effect on human genetic material: in vitro study. Aristotle University Medical Journal, 40 (2), 33–39.
   Google Scholar
• Durbin, S., et al., 2009. Reduced grating acuity associated with retinal toxicity in children with ınfantile spasms on vigabatrin therapy. Investigative ophthalmology & Visual Science, 50 (8), 4011–4016.
   PubMed Web of Science ®Google Scholar
• Eastmond, D.A., and Tucker, J.D., 1989. Identification of aneuploidy-inducing agents using cytokinesis-blocked human lymphocytes and an antikinetochore antibody. Environmental and Molecular Mutagenesis, 13 (1), 34–43.
   PubMed Web of Science ®Google Scholar
• Eke, T., Talbot, J.F., and Lawden, M.C., 1997. Severe persistent visual field constriction associated with vigabatrin. BMJ, 314, 180–181.
   PubMed Web of Science ®Google Scholar
• Eldemir Okay, Y., et al., 2022. In vitro cytogenotoxic evaluation of aripiprazole on human peripheral lymphocytes and computational molecular docking analysis. Drug and Chemical Toxicology, 1–7. doi:10.1080/01480545.2022.2135008
   PubMed Web of Science ®Google Scholar
• Epel, D., 1963. The effects of carbon monoxide ınhibition of ATP level and the date of mitosis in sea urchin egg. Journal of Cell Biology, 17 (2), 315–319.
   PubMed Web of Science ®Google Scholar
• Evans, H.J., 1984. Human peripheral blood lymphocytes for the analysis of chromosome aberrations in mutagen tests. In: B.J. Kilbey, M. Legator, W. Nichols and C. Ramel, eds. Handbook of Mutagenicity Test Procedures. Amsterdam: Elsevier, 405–427.
   Google Scholar
• Falco-Walter, J., 2020. Epilepsy-definition, classification, pathophysiology, and epidemiology. Seminars in Neurology, 40 (6), 617–623.
   PubMedGoogle Scholar
• Fenech, M., 2000. The in vitro micronucleus technique. Mutation research, 455 (1-2), 81–95.
   PubMed Web of Science ®Google Scholar
• Foroozan, R., 2018. Vigabatrin: lessons learned from the united states experience. Journal of Neuro-Ophthalmology, 38 (4), 442–450.
   PubMed Web of Science ®Google Scholar
• Gaitatzis, A., and Sander, J.W., 2013. The long-term safety of antiepileptic drugs. CNS drugs, 27 (6), 435–455.
   PubMed Web of Science ®Google Scholar
• Galloway, S.M., et al., 1998. DNA synthesis ınhibition as an indirect mechanism of chromosome aberrations, comparison of DNA-reactive and non-DNA-reactive clastogens. Mutation research, 400 (1-2), 169–186.
   PubMed Web of Science ®Google Scholar
• Glover, T.W., 2006. Common fragile sites. Cancer letters, 232 (1), 4–12.
   PubMed Web of Science ®Google Scholar
• Glover, T.W., et al., 2005. Mechanisms of common fragile site instability. Human Molecular Genetics, 14 (suppl_2), R197–R205.
   PubMedGoogle Scholar
• Hilliard, C.A., et al., 1998. Chromosome aberrations in vitro related to cytotoxicity of nonmutagenic chemicals and metabolic poisons. Environmental and Molecular Mutagenesis, 31 (4), 316–326.
   PubMed Web of Science ®Google Scholar
• Holmes, L.B., et al., 2001. The teratogenicity of anticonvulsant drugs. The New England Journal of Medicine, 344 (15), 1132–1138.
   PubMed Web of Science ®Google Scholar
• Husunet, M.T., et al., 2022. Investigation of the genotoxic effects of patent blue V (E131) in human peripheral lymphocytes and in silico molecular docking. Drug and Chemical Toxicology, 45 (4), 1780–1786.
   PubMed Web of Science ®Google Scholar
• Jain, A.K., and Andsorbhoy, R.K., 1988. Cytogenetical studies on the effects of some chlorinated pesticides III. Concluding Remarks. Cytologia, 53 (3), 427–436.
   Web of Science ®Google Scholar
• Jastrzembski, B., Locke, J., and Wan, M.J., 2020. Clinical implications and cost of electroretinography screening for vigabatrin toxicity. Canadian Journal of Ophthalmology, Journal Canadien D'ophtalmologie, 55 (3), e98–e100.
   PubMed Web of Science ®Google Scholar
• Juncosa, J.I., et al., 2018. Design and mechanism of (S)-3-amino-4-(difluoromethylenyl) cyclopent-1-ene-1-carboxylic acid, a highly potent γ-aminobutyric acid aminotransferase inactivator for the treatment of addiction. Journal of the American Chemical Society, 140 (6), 2151–2164.
   PubMed Web of Science ®Google Scholar
• Karlsson, A., et al., 1974. Effect of the convulsive agent 3 mercaptopropionic acid on the levels of GABA, other amino acids and glutamate decarboxylase in different regions of the rat brain. Biochemical pharmacology, 23 (21), 3053–3061.
   PubMed Web of Science ®Google Scholar
• Kayraldiz, A., et al., 2017. Evaluation of genotoxic effects of levofloxacin in human peripheral lymphocytes. Indian Journal of Applied Research, 7 (4), 622–625.
   Google Scholar
• Kirkland, D.J., and Muller, L., 2000. Interpretation of the Biological Relevance of Genotoxicity Test Results, the Importance of Thresholds. Mutation research, 464 (1), 137–147.
   PubMed Web of Science ®Google Scholar
• Kirsch-Volders, M., et al., 2003. Report from the ın vitro micronucleus assay working Group. Mutation Research, 540 (2), 153–163.
   PubMed Web of Science ®Google Scholar
• Krogsgaard-Larsen, P., 1981. Gamma aminobutyric acid agonists, antagonists, and uptake inhibitors: design and therapeutic aspects. Journal of Medicinal Chemistry, 24 (12), 1377–1383.
   PubMed Web of Science ®Google Scholar
• Landmark, C.J., 2008. Antiepileptic drugs in non-epilepsy disorders. CNS drugs, 22 (1), 27–47.
   PubMed Web of Science ®Google Scholar
• Lee, C.Y., et al., 2016. The effects of antiepileptic drugs on the growth of glioblastoma cell lines. Journal of Neuro-Oncology, 127 (3), 445–453.
   PubMed Web of Science ®Google Scholar
• Narzullo, S., 2020. Molecular docking, ADMET study and in vivo pharmacological research of N-(3, 4-dimetoxyphenyl)-2-{[2-methyl-6-(pyridine-2-yl)-pyrimidin-4-yl] thio} acetamide as a promising anticonvulsant. Research Results in Pharmacology, 6 (2), 27–41.
   Google Scholar
• Nasab, R.R., et al., 2017. Docking study, synthesis and antimicrobial evaluation of some novel 4-anilinoquinazoline derivatives. Research in Pharmaceutical Sciences, 12 (5), 425–433.
   PubMed Web of Science ®Google Scholar
• Norppa, H., et al., 2006. Chromosomal Aberrations and SCEs as Biomarkers of Cancer Risk. Mutation Research, 600 (1-2), 37–45.
   PubMed Web of Science ®Google Scholar
• Padmanabhan, R., et al., 2010. Vigabatrin (VGB) administered during late gestation lowers maternal folate concentration and causes pregnancy loss, fetal growth restriction and skeletal hypoplasia in the mouse. Reproductive toxicology (Elmsford, N.Y.), 29 (3), 366–377.
   PubMed Web of Science ®Google Scholar
• Patsalos, P.N., Spencer, E.P., and Berry, D.J., 2018. Therapeutic drug monitoring of antiepileptic drugs in epilepsy: a 2018 update. Therapeutic drug Monitoring, 40 (5), 526–548.
   PubMed Web of Science ®Google Scholar
• Perry, P. E., and Thomson, E. J., 1984. The methodology of sister chromatid exchanges. In: B. J. Kilbey, M. Legator, W. Nichols, C. Ramel, eds. Handbook of Mutagenicity Test Procedures, 2nd edn. Amsterdam: Elsevier, 459–529.
   Google Scholar
• Perucca, E., and Tomson, T., 2011. The pharmacological treatment of epilepsy in adults. The Lancet. Neurology, 10 (5), 446–456.
   PubMed Web of Science ®Google Scholar
• Perucca, P., Scheffer, I.E., and Kiley, M., 2018. The management of epilepsy in children and adults. The Medical Journal of Australia, 208 (5), 226–233.
   PubMed Web of Science ®Google Scholar
• Pippenger, C.E., 2003. Pharmacology of neural tube defects. Epilepsia, 44, 24–32.
   PubMed Web of Science ®Google Scholar
• Ricci, C.G., and Netz, P.A., 2009. Docking studies on DNA-ligand interactions: building and application of a protocol to identify the binding mode. Journal of Chemical İnformation and Modeling, 49 (8), 1925–1935.
   PubMed Web of Science ®Google Scholar
• Rothfuss, A., et al., 2000. Induced micronucleus frequencies in peripheral lymphocytes as a screening test for carries of a BRCA1 mutation in breast cancer families. Cancer Research, 60, 390–394.
   PubMed Web of Science ®Google Scholar
• Sankar, R., and Spence, S.J., 2001. Visual field defects and other ophthalmological disturbances associated with vigabatrin. Drug safety, 24 (5), 385–404.
   PubMed Web of Science ®Google Scholar
• Sankaraneni, R., and Lachhwani, D., 2015. Antiepileptic drugs–a review. Pediatric Annals, 44 (2), 36–42.
   PubMed Web of Science ®Google Scholar
• Sanner, M.F., 1999. Python: A programming language for software integration and development. Journal of Molecular Graphics & Modelling, 17 (1), 57–61. English.
   PubMed Web of Science ®Google Scholar
• Savage, J.R., 1993. Update on Target Theory as Applied to Chromosomal Aberrations. Environmental and Molecular Mutagenesis, 22 (4), 198–207.
   PubMed Web of Science ®Google Scholar
• Scharfman, H.E., 2007. The Neurobiology of Epilepsy. Current neurology and Neuroscience Reports, 7 (4), 348–354.
   PubMed Web of Science ®Google Scholar
• Shaffer, L. G., McGowan-Jordan, J., & Schmid, M. (Eds.). 2013. ISCN 2013: an international system for human cytogenetic nomenclature (2013). Basel: Karger Medical and Scientific Publishers.
   Google Scholar
• Shityakov, S., and Förster, C., 2014. In silico predictive model to determine vector-mediated transport properties for the blood–brain barrier choline transporter. Advances and Applications in Bioinformatics and Chemistry : AABC, 7, 23–36.
   PubMedGoogle Scholar
• Sills, G.J., and Rogawski, M.A., 2020. Mechanisms of action of currently used antiseizure drugs. Neuropharmacology, 168, 107966.
   PubMed Web of Science ®Google Scholar
• Singh, D., JethANi, S.L., and Dubey, A., 2013. Vigabatrin induced cell loss in the cerebellar cortex of albino rats. Journal of Clinical and Diagnostic Research : JCDR, 7 (11), 2555–2558.
   PubMedGoogle Scholar
• Singh, N.P., et al., 1988. A Simple Technique for Quantitation of Low Levels of DNA Damage in Individual Cells. Experimental cell Research, 175 (1), 184–191.
   PubMed Web of Science ®Google Scholar
• Sousa, K., et al., 2017. Neurobehavioral Effects of Vigabatrin and its Ability to Induce DNA Damage in Brain Cells after Acute Treatment in Rats. Psychopharmacology, 234 (1), 129–136.
   PubMed Web of Science ®Google Scholar
• Speit, G., and Haupter, S., 1985. On the mechanism of differential Giemsa staining of bromodeoxyuridine-substituted chromosomes. Human Genetics, 70 (2), 126–129.
   PubMed Web of Science ®Google Scholar
• Titenko-Holland, N., et al., 1997. Genotoxicity of Malathion in Human Lymphocytes Assessed Using the Micronucleus Assay In Vitro and In Vivo: a Study of Malathion- Exposed Workers. Mutation Research, 388 (1), 85–95.
   PubMed Web of Science ®Google Scholar
• Topaktaş, M., and Speit, G., 1990. Sister chromatid exchange (SCE) testinin mutajenite ve kanserojenitenin belirlenmesinde kullanılması. ÇÜ Sağlık Bil. Der, 5 (1), 2.
   Google Scholar
• Tran, A., et al., 1998. Vigabatrin: placental transfer ‘ooin vivo ‘ox and excretion into breast milk of the enantiomers. British journal of Clinical Pharmacology, 45 (4), 409–411.
   PubMed Web of Science ®Google Scholar
• Unal, F., et al., 2016. Answer to letter sent by Dr. MD Rogers (Chairman of the International Glutamate Technical Committee (IGTC), Belgium) related to Ataseven et al. article published in Food and Chemical Toxicology, 91: 8-18. Food and Chemical Toxicology : An İnternational Journal Published for the British Industrial Biological Research Association, 94, 262–267.
   PubMed Web of Science ®Google Scholar
• Vock, E.H., et al., 1998. Discrimination between genotoxicity and cytotoxicity in the ınduction of DNA doublestrand breaks in cells treated with etoposide, melphalan, cisplatin, potassium cyanide, triton X-100 and g-irradiation. Mutation Research, 413 (1), 83–94.
   PubMed Web of Science ®Google Scholar
• Waterhouse, E.J., Mims, K.N., and Gowda, S.N., 2009. Treatment of refractory complex partial seizures: role of vigabatrin. Neuropsychiatric disease and Treatment, 5, 505–515.
   PubMed Web of Science ®Google Scholar
• 2019. WHO Epilepsy: A public Health Initiative. Geneva: World Health Organization.
   Google Scholar
• Witczak, M., et al., 2010. Evaluation of chromosome aberrations, sister chromatid exchange and micronuclei in cultured cord-blood lymphocytes of newborns of women treated for epilepsy during pregnancy. Mutation Research, 701 (2), 11–117.
   Web of Science ®Google Scholar